• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 C 反应蛋白水平可作为预测甲型 H1N1 流感大流行病毒感染患者预后的早期指标。

C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection.

机构信息

Department of Internal Medicine D, Tel-Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

出版信息

BMC Infect Dis. 2010 Oct 4;10:288. doi: 10.1186/1471-2334-10-288.

DOI:10.1186/1471-2334-10-288
PMID:20920320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2959060/
Abstract

BACKGROUND

Data for predicting which patients with pandemic influenza A (H1N1) infection are likely to run a complicated course are sparse. We retrospectively studied whether the admission serum C-reactive protein (CRP) levels can serve as a predictor of illness severity.

METHODS

Included were all consecutive adult patients who presented to the emergency department (ED) between May-December, 2009 with a flu-like illness, a confirmed diagnosis of pandemic influenza A (H1N1) infection and a serum CRP level measured within 24 hours of presentation. Patients with a proven additional concurrent acute illness (e.g., bacteremia) were excluded. We used the ROC curve analysis, Kaplan-Meier curves and the Cox proportional hazard model to evaluate the predictive ability of CRP as a prognostic factor.

RESULTS

Seventeen (9%) of the 191 enrolled patients were admitted to the intensive care unit (ICU), of whom eight (4%) required mechanical ventilation and three (2%) died. The median admission serum CRP levels were significantly higher among patients who required subsequent ICU care and mechanical ventilation than among patients who did not (123 mg/L and 112 mg/L vs. 40 mg/L, p < .001 and 43 mg/L, p = .017, respectively). A Cox proportional hazard model identified admission serum CRP levels and auscultatory findings over the lungs as independent prognostic factors for ICU admission. Admission serum CRP levels were the only independent prognostic factor for mechanical ventilation. Thirty days after presenting to the ED, none of the patients with admission serum CRP level <28 mg/L (lower tertile) required either ICU admission or mechanical ventilation. At the same time point, 19% of the patients with admission serum CRP level ≥70 mg/L (upper tertile) needed to be admitted to the ICU and 8% of the same upper tertile group required mechanical ventilation. The differences in the rates between the lower vs. upper tertile groups were significant (Log-Rank p < .001 for ICU and p < .024 for mechanical ventilation).

CONCLUSIONS

In our study group, serum CRP levels obtained in the early ED admission stage from patients presenting with pandemic H1N1 influenza A infection were found to serve as a useful gauge for predicting disease course and assisting in patient management.

摘要

背景

目前对于预测哪些甲型流感(H1N1)感染患者可能出现病情复杂的相关数据较为匮乏。本研究旨在回顾性分析入院时血清 C 反应蛋白(CRP)水平是否可以作为疾病严重程度的预测指标。

方法

连续纳入 2009 年 5 月至 12 月期间因流感样疾病就诊于急诊科、确诊为甲型 H1N1 流感感染且入院 24 小时内检测 CRP 水平的成年患者。排除同时患有明确的其他急性疾病(如菌血症)的患者。采用 ROC 曲线分析、Kaplan-Meier 曲线和 Cox 比例风险模型来评估 CRP 作为预后因素的预测能力。

结果

191 例纳入患者中 17 例(9%)收入重症监护病房(ICU),其中 8 例(4%)需要机械通气,3 例(2%)死亡。需要后续 ICU 治疗和机械通气的患者入院时血清 CRP 中位数明显高于不需要的患者(123mg/L 和 112mg/L 比 40mg/L,p<0.001 和 43mg/L,p=0.017)。Cox 比例风险模型确定入院时血清 CRP 水平和肺部听诊结果为 ICU 入住的独立预后因素。入院时血清 CRP 水平是机械通气的唯一独立预后因素。在急诊科就诊后 30 天,入院时 CRP 水平<28mg/L(下三分之一)的患者无一例需要 ICU 入住或机械通气。同时,入院时 CRP 水平≥70mg/L(上三分之一)的患者中有 19%需要入住 ICU,8%的上三分之一组需要机械通气。下三分之一组与上三分之一组之间的差异有统计学意义(ICU 组 Log-Rank p<0.001,机械通气组 p<0.024)。

结论

在本研究组中,从甲型 H1N1 流感感染患者急诊科早期入院时获得的血清 CRP 水平可作为预测疾病进程和协助患者管理的有用指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc6/2959060/45a44e583d39/1471-2334-10-288-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc6/2959060/ddfeae284c48/1471-2334-10-288-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc6/2959060/4ddc2f91ad75/1471-2334-10-288-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc6/2959060/f9f1d9b1c91a/1471-2334-10-288-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc6/2959060/45a44e583d39/1471-2334-10-288-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc6/2959060/ddfeae284c48/1471-2334-10-288-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc6/2959060/4ddc2f91ad75/1471-2334-10-288-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc6/2959060/f9f1d9b1c91a/1471-2334-10-288-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cc6/2959060/45a44e583d39/1471-2334-10-288-4.jpg

相似文献

1
C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection.血清 C 反应蛋白水平可作为预测甲型 H1N1 流感大流行病毒感染患者预后的早期指标。
BMC Infect Dis. 2010 Oct 4;10:288. doi: 10.1186/1471-2334-10-288.
2
Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection.降钙素原和 C 反应蛋白在严重 2009 年 H1N1 流感感染中的应用。
Intensive Care Med. 2010 Mar;36(3):528-32. doi: 10.1007/s00134-009-1746-3.
3
Clinical features, treatments and outcomes of influenza A (H1N1) 2009 among the hospitalized patients in the clinic for infectious diseases in Novi Sad.诺维萨德传染病诊所住院患者中2009年甲型H1N1流感的临床特征、治疗方法及结果
Vojnosanit Pregl. 2013 Feb;70(2):155-62. doi: 10.2298/vsp1302155c.
4
Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable.2009 年甲型 H1N1 流感肺炎:CURB-65 评分预测严重程度和鼻咽取样诊断不可靠。
PLoS One. 2010 Sep 21;5(9):e12849. doi: 10.1371/journal.pone.0012849.
5
Clinical diagnosis of pandemic A(H1N1) 2009 influenza in children with negative rapid influenza diagnostic test by lymphopenia and lower C-reactive protein levels.儿童甲型 H1N1 流感大流行的临床诊断:快速流感诊断检测阴性,伴淋巴细胞减少和 C 反应蛋白水平降低。
Influenza Other Respir Viruses. 2014 Jan;8(1):91-8. doi: 10.1111/irv.12182. Epub 2013 Nov 7.
6
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome.危重症患者甲型H1N1流感大流行病毒感染的诊断延迟及其对临床结局的影响。
Crit Care. 2016 Oct 23;20(1):337. doi: 10.1186/s13054-016-1512-1.
7
Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection.2009 年甲型 H1N1 流感病毒感染患者重症疾病的相关因素。
CMAJ. 2010 Feb 23;182(3):257-64. doi: 10.1503/cmaj.091884. Epub 2010 Jan 21.
8
Comparison of clinical features and outcomes of hospitalized adult patients with novel influenza A (H1N1) pneumonia and other pneumonia.比较住院成人新型甲型 H1N1 流感肺炎与其他肺炎的临床特征和结局。
Acad Emerg Med. 2013 Jan;20(1):46-53. doi: 10.1111/acem.12062.
9
Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?出现流感样症状的H1N1阳性和阴性患者入院时的临床和实验室检查结果是否存在差异?
BMC Res Notes. 2011 Jan 7;4:4. doi: 10.1186/1756-0500-4-4.
10
Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit.重症监护病房收治的医院获得性甲型流感病毒(H1N1)pdm09 患者的特征。
J Hosp Infect. 2017 Feb;95(2):200-206. doi: 10.1016/j.jhin.2016.12.017. Epub 2016 Dec 30.

引用本文的文献

1
Potential of biomarkers of ageing in predicting severity of influenza virus infection and vaccination efficacy.衰老生物标志物在预测流感病毒感染严重程度和疫苗接种效果方面的潜力。
NPJ Aging. 2025 Jul 1;11(1):56. doi: 10.1038/s41514-025-00212-5.
2
Latent classes of adverse childhood experiences and changes in inflammation across middle age among urban-dwelling adults.城市成年居民童年不良经历的潜在类别与中年时期炎症的变化
Brain Behav Immun. 2025 Jun 17;129:494-504. doi: 10.1016/j.bbi.2025.06.018.
3
Predicting major clinical events among Canadian adults with laboratory-confirmed influenza infection using the influenza severity scale.

本文引用的文献

1
Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections.甲型 H1N1 流感 2009 年大流行病毒致死病例的肺部病理学观察
Arch Pathol Lab Med. 2010 Feb;134(2):235-43. doi: 10.5858/134.2.235.
2
Swine-origin influenza A (H1N1) viral infection: radiographic and CT findings.猪源甲型 H1N1 流感病毒感染:影像学和 CT 表现。
AJR Am J Roentgenol. 2009 Dec;193(6):1494-9. doi: 10.2214/AJR.09.3625.
3
Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection.新型猪源甲型 H1N1 流感病毒(S-OIV)感染的胸部 X 线和 CT 表现。
使用流感严重程度量表预测加拿大成人实验室确诊流感感染后的主要临床事件。
Sci Rep. 2024 Aug 8;14(1):18378. doi: 10.1038/s41598-024-67931-9.
4
Machine-learning-algorithms-based diagnostic model for influenza A in children.基于机器学习算法的儿童甲型流感诊断模型。
Medicine (Baltimore). 2023 Dec 1;102(48):e36406. doi: 10.1097/MD.0000000000036406.
5
Association of mTOR Pathway and Conformational Alterations in C-Reactive Protein in Neurodegenerative Diseases and Infections.mTOR 通路与 C-反应蛋白构象改变在神经退行性疾病和感染中的关联。
Cell Mol Neurobiol. 2023 Nov;43(8):3815-3832. doi: 10.1007/s10571-023-01402-z. Epub 2023 Sep 4.
6
The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults.生物标志物在成人流感和新冠病毒感染社区获得性肺炎中的作用
Antibiotics (Basel). 2023 Jan 12;12(1):161. doi: 10.3390/antibiotics12010161.
7
Deficiency of C-reactive protein or human C-reactive protein transgenic treatment aggravates influenza A infection in mice.缺乏 C-反应蛋白或人 C-反应蛋白转基因治疗可加重小鼠流感 A 感染。
Front Immunol. 2022 Oct 6;13:1028458. doi: 10.3389/fimmu.2022.1028458. eCollection 2022.
8
Age-Dependent Biomarkers for Prediction of In-Hospital Mortality in COVID-19 Patients.用于预测COVID-19患者院内死亡率的年龄依赖性生物标志物
J Clin Med. 2022 May 10;11(10):2682. doi: 10.3390/jcm11102682.
9
Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis.C 反应蛋白能否预测初级保健患者流感样疾病的恢复时间和奥司他韦治疗的获益?一项随机对照试验的二次分析。
Scand J Prim Health Care. 2021 Dec;39(4):527-532. doi: 10.1080/02813432.2021.2006482. Epub 2021 Dec 1.
10
A literature review of severity scores for adults with influenza or community-acquired pneumonia - implications for influenza vaccines and therapeutics.成人流感或社区获得性肺炎严重程度评分的文献综述 - 对流感疫苗和治疗的影响。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5460-5474. doi: 10.1080/21645515.2021.1990649. Epub 2021 Nov 10.
AJR Am J Roentgenol. 2009 Dec;193(6):1488-93. doi: 10.2214/AJR.09.3599.
4
Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.2009年甲型H1N1流感大流行致死病例肺组织标本中的细菌合并感染 - 美国,2009年5月至8月
MMWR Morb Mortal Wkly Rep. 2009 Oct 2;58(38):1071-4.
5
Emergence of a novel swine-origin influenza A (H1N1) virus in humans.一种新型猪源甲型流感病毒(H1N1)在人类中的出现。
N Engl J Med. 2009 Jun 18;360(25):2605-15. doi: 10.1056/NEJMoa0903810. Epub 2009 May 7.
6
Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome.严重急性呼吸综合征中细胞因子/趋化因子谱的时间变化及肺部受累情况
Respirology. 2006 Nov;11(6):715-22. doi: 10.1111/j.1440-1843.2006.00942.x.
7
Hematological and biochemical factors predicting SARS fatality in Taiwan.台湾地区严重急性呼吸综合征(SARS)死亡的血液学和生化预测因素
J Formos Med Assoc. 2006 Jun;105(6):439-50. doi: 10.1016/S0929-6646(09)60183-2.
8
Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome.严重急性呼吸综合征患者的临床表现及炎性细胞因子反应
J Formos Med Assoc. 2005 Oct;104(10):715-23.
9
The course of C-reactive protein response in untreated upper respiratory tract infection.未经治疗的上呼吸道感染中C反应蛋白的反应过程。
Br J Gen Pract. 2004 Sep;54(506):653-8.
10
Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients.非典患者的临床表现、实验室检查结果及治疗结果。
Emerg Infect Dis. 2004 May;10(5):818-24. doi: 10.3201/eid1005.030640.